Researcher
Jens De Vos
- Keywords:Medicine, Applied biological sciences, biotechnology
- Disciplines:Agricultural, veterinary and food sciences
Affiliations
- Medical Imaging (Research group)
Member
From1 Jan 2011 → Today - Cellular and Molecular Immunology (Research group)
Member
From1 Oct 2009 → Today - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Supporting clinical sciences (Department)
Member
From1 Dec 2016 → 30 Nov 2020 - Supporting clinical sciences (Department)
Member
From1 Oct 2014 → 30 Nov 2020 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2010 → 30 Sep 2014 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From16 Aug 2008 → 2 Jul 2010
Publications
1 - 10 of 13
- Phase I trial of 131I-GMIB-Anti-HER2-VHH1, a new promising candidate for HER2-targeted radionuclide therapy in breast cancer patients(2021)
Authors: Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, Francois P Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D Windhorst, Frank Van Der Aa, et al.
Pages: 1097-1105 - A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells(2017)
Authors: Alexander Balhuizen, Sam Massa, Iris Mathijs, Jean-Valery Turatsinze, Jens De Vos, Stéphane Demine, Catarina Xavier, Olatz Villate, Isabelle Millard, Dominique Egrise, et al.
Pages: 15130 - I-131-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment(2017)
Authors: Matthias D'Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszynski, Yann G J Sterckx, Sam Massa, Geert Raes, Vicky Caveliers, Michael R Zalutsky, Tony Lahoutte, et al.
Pages: 6616-6628 - Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging(2014)
Authors: Sam Massa, Catarina Xavier, Jens De Vos
Pages: 979-988 - Specific Targeting of Atherosclerotic Plaques in ApoE(-/-) Mice Using a New Camelid sdAb Binding the Vulnerable Plaque Marker LOX-1.(2014)
Authors: Jens De Vos, Iris Mathijs, Catarina Xavier, Sam Massa, Ulrich Wernery
Pages: 690-698 - Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: Adjusting the bullet to its target(2013)
Authors: Jens De Vos
Pages: 1149-1160 - Nanobodies Targeted Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions(2012)Volume: 14
Authors: Alexis Broisat, Jakub Toczek, Jens De Vos, Laurent M. Riou, Sandrine Martin, Mitra Ahmadi, Daniel Fagret, Catherine Ghezzi
- Site-specific labeling of his-tagged Nanobodies with 99mTc: A practical guide(2012)Series: Methods in Molecular Biology
Authors: Catarina Xavier, Ilse Vaneycken, Jens De Vos, Sam Massa
Pages: 485-490Number of pages: 6 - Molecular Imaging using Nanobodies: a case study(2012)Series: Methods in Molecular Biology
Authors: Catarina Xavier, Ilse Vaneycken, Jens De Vos, Sam Massa
Pages: 559-567Number of pages: 9 - Development of LOX-1 Nanobodies for in vivo imaging of atherosclerosis(2012)
Authors: Jens De Vos, Jakub Toczek, Catherine Ghezzi
Patents
1 - 6 of 6
- Anti-macrophage mannose receptor single variable domains for use in cardiovascular diseases (Inventor)
- Radio-labelled antibody fragments for use in the prevention and/or treatment of cancer (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)
- Radiolabelled antibody fragments for use in treating cancer (Inventor)